This website is no longer being updated. NHS Shropshire, Telford and Wrekin Clinical Commissioning Group was abolished on 1 July 2022 and its functions were transferred to a new organisation, NHS Shropshire, Telford and Wrekin Integrated Care Board.


Please visit to continue your search, and find out more about the new organisation.

Updated guidelines for diabetes patients on glucose monitoring

27 April 2022

On Thursday 31 March 2022, the National Institute for Health and Care Excellence (NICE) updated the recommendations in their diabetes guidance in relation to glucose monitoring. This applies to patients with both type 1 and type 2 diabetes.

Shropshire, Telford and Wrekin Clinical Commissioning Group are aware of this updated guidance and patients should be assured that we are working closely with diabetes specialist colleagues and other local stakeholders in relation to the implementation of this updated guidance.

Our aim is to maximise benefits, prioritise diabetes patients with the greatest clinical need, and allow all patients access to the best possible treatment for their clinical circumstances.

We are politely asking our patients to please bear with us whilst we complete this process.

Further information will be released when available. Click here to read more from NICE

Page last updated 27 April 2022